Cerebrospinal fluid (CSF) β-site amyloid precursor protein cleaving enzyme 1 (BACE1), neurogranin and the neurogranin/BACE1 ratio are proposed markers for Alzheimer’s disease. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.